# A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

> **NCT06342700** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 28 (actual)

## Conditions studied

- Autoimmune Disorder
- Healthy Volunteers

## Interventions

- **DRUG:** Rilzabrutinib crystalline form
- **DRUG:** Rilzabrutinib amorphous form

## Key facts

- **NCT ID:** NCT06342700
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-25
- **Primary completion:** 2024-04-23
- **Final completion:** 2024-04-23
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06342700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06342700, "A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT06342700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*